HOME > MARKETS > MARKET COMMENTARY
  MARKET COMMENTARY
EQUITY
Mankind Pharma trades in green despite reporting 18% fall in Q1 consolidated net profit
Aug-01-2025

Mankind Pharma is currently trading at Rs. 2569.80, up by 2.05 points or 0.08% from its previous closing of Rs. 2567.75 on the BSE.

The scrip opened at Rs. 2567.75 and has touched a high and low of Rs. 2645.90 and Rs. 2560.00 respectively. So far 26808 shares were traded on the counter.

The BSE group 'A' stock of face value Rs. 1 has touched a 52 week high of Rs. 3050.00 on 23-Dec-2024 and a 52 week low of Rs. 1910.10 on 05-Aug-2024.

Last one week high and low of the scrip stood at Rs. 2645.90 and Rs. 2506.55 respectively. The current market cap of the company is Rs. 105726.66 crore.

The promoters holding in the company stood at 72.68%, while Institutions and Non-Institutions held 24.53% and 2.79% respectively.

Mankind Pharma has reported 18.37% fall in its net profit at Rs 412.76 crore for first quarter ended June 30, 2025 as compared to Rs 505.66 crore for the same quarter in the previous year. However, the total income of the company increased by 3.86% at Rs 2605.58 crore for Q1FY26 as compared to Rs 2508.66 crore for the corresponding quarter previous year.

On consolidated basis, the company has reported 18.30% fall in its net profit at Rs 438.32 crore for Q1FY26 as compared to Rs 536.49 crore for the same quarter in the previous year. However, the total income of the company increased by 23.02% at Rs 3650.23 crore for Q1FY26 as compared to Rs 2967.25 crore for the corresponding quarter previous year.


  RELATED NEWS >>